Flow Cytometry Market By Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), By Product (Analyzer, Sorter, and Reagents and Consumables), By Application (Research, Industrial, and Clinical), By End User (Hospitals, Clinical Testing Labs, Academics Institutes, and Commercial organizations), and By Region - Trends, Analysis and Forecast till 2034

With a projected growth rate of 9.6%, the flow cytometry market, which was valued at US$ 5.4 billion in 2024, is expected to reach USD 13.5 Bllion by 2034.

To investigate the characteristics of cells or other particles, a laboratory technique known as flow cytometry is employed. During the process, a flow cytometer device is filled with a fluid-suspended sample of cells or other particles. Flow cytometry is a tool used in the examination of immunodeficiencies, autoimmune diseases, and infectious diseases that classify and count various types of white blood cells. It is used to diagnose and classify lymphoma and leukemia. Flow cytometry is commonly employed as a supplemental test after a white blood cell scan (WBC) or complete blood count (CBC). This is particularly valid if Preliminary investigations showed the presence of immature blood cells, abnormal cell counts, or an increased lymphocyte count.